Celera Settles Some Suits Related to Quest Diagnostics Acquisition

Celera and other defendants have entered into a memorandum of understanding in putative class action lawsuits stemming from the company's proposed acquisition by Quest Diagnostics.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.